Emergent BioSolutions' GAAP net income for 2021 was $230.9 million, down 24.3% from $305.1 million in the previous year. Revenue increased 15.3% to $1.793 billion from $1.555 billion a year earlier.
Emergent BioSolutions' GAAP net income for 2021 was $230.9 million, down 24.3% from $305.1 million in the previous year. Revenue increased 15.3% to $1.793 billion from $1.555 billion a year earlier. 
sec.gov
English (US) 